Annual report pursuant to Section 13 and 15(d)

Stock Options

v3.21.2
Stock Options
12 Months Ended
Aug. 31, 2020
Share-based Payment Arrangement [Abstract]
STOCK OPTIONS
19. STOCK OPTIONS

(a) Stock option plan

The Company has a stock option plan which allows the Board of Directors of the Company to grant options to acquire common shares of the Company to directors, officers, key employees and consultants. The option price, term and vesting are determined at the discretion of the Board of Directors, subject to certain restrictions as required by the policies of the TSX Venture Exchange. The stock option plan is a 20% fixed number plan with a maximum of 54,890,067 common shares reserved for issue at August 31, 2020.


On August 7, 2020, the Company issued a five-year option exercisable for 3,000,000 common shares, vesting over nine months, at an exercise price of CAD$0.085 per share to its newly appointed Chief Operating Officer.


On August 20, 2020, the Company issued a six-month option exercisable for 2,220,000 common shares, vesting immediately, at an exercise price of CAD$0.11 per share to a lender.


During the year ended August 31, 2020 the share-based compensation expense of $887,818 (2019 - $916,240) relates to the vesting of options granted during the current fiscal year and the fiscal year ended August 31, 2018.


(b) Stock options

Stock option transactions under the stock option plan were:


Year ended
August 31, 2020
Year ended
August 31, 2019
Number of Options Weighted
average
exercise
price
Number of options Weighted
average
exercise
price
Balance, beginning of period 9,808,333 CAD$ 1.20 9,858,333 CAD$ 1.22
Options granted 5,220,000 CAD$ 0.10 - -
Options forfeited (5,558,333 ) CAD$ 1.14 (50,000 ) CAD$ 4.80
Balance, end of period 9,470,000 CAD$ 0.63 9,808,333 CAD$ 1.20

Stock options outstanding and exercisable as at August 31, 2020 are:


Expiry Date Exercise
Price
Options
Outstanding
Options
Exercisable
February 20, 2021 CAD$ 0.110 2,220,000 2,220,000
August 7, 2025 CAD$ 0.085 3,000,000 -
November 30, 2027 CAD$ 2.270 950,000 950,000
June 5, 2028 CAD$ 1.000 3,300,000 2,475,000
9,470,000 5,645,000
Weighted average remaining contractual life 5.1 years 4.8 years

The total grant-date fair value of stock options granted during the year ended August 31, 2020 was $259,220, determined by applying the Black-Scholes option pricing model with the following inputs and assumptions:


Year ended
August 31,
2020
Conversion price CAD$0.085 to CAD$0.11
Risk free interest rate 0.19 to 0.30 %
Expected life of derivative liability 0.5 to 5 years
Expected volatility of underlying stock 135 to 192 %
Expected dividend rate 0 %